Eton Pharmaceuticals, Inc. ETON EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Eton Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s EBITDA margin?
- Eton Pharmaceuticals, Inc. (ETON) reported EBITDA margin of -0.6% in Q3 2025.
- How has Eton Pharmaceuticals, Inc.'s EBITDA margin changed year-over-year?
- Eton Pharmaceuticals, Inc.'s EBITDA margin increased by 94.7% year-over-year, from -11.8% to -0.6%.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s EBITDA margin?
- Over 2 years (2020 to 2024), Eton Pharmaceuticals, Inc.'s EBITDA margin has grown at a -99.0% compound annual growth rate (CAGR), from -67,846.2% to -6.6%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.